Genuine concern gets amplified into fear-mongering
Finally, a four-year, multicenter, clinical trial in 421 diabetic patients with distal symmetric sensorimotor polyneuropathy found no difference between oral administration of 600 mg/day of lipoic and placebo on the primary endpoint, a composite score that assessed neuropathic impairment of the lower limbs and nerve conduction (78)
Other recognised side effects include: Fatigue and dizziness, particularly during the initial weeks of treatment Headache, classified as 'common' in product information Hypoglycaemia (low blood sugar), primarily a risk in patients also taking insulin or sulfonylureas
For adults over 40 specifically, faster isn't always better slower, smarter loss with muscle preservation produces better long-term outcomes
As we age we often experience fatigue, insomnia, weight gain, and many other symptoms
10.2353/ajpath.2009.080804 113